Johnson Johnson Company Top Insiders
JNJ Stock | USD 156.76 1.42 0.90% |
Nearly 78 percent of Johnson Johnson's insiders are selling. The analysis of insiders' sentiment of trading Johnson Johnson stock suggests that many insiders are terrified at this time. Johnson Johnson employs about 131.9 K people. The company is managed by 54 executives with a total tenure of roughly 305 years, averaging almost 5.0 years of service per executive, having 2442.59 employees per reported executive.
Jorge Mesquita Chairman Executive Vice President Worldwide Chairman - Consumer |
Jennifer Taubert Chairman Executive Vice President - Worldwide Chairman, Pharmaceuticals |
Johnson Johnson's Insider Buying Vs Selling
22
Selling | Buying |
Latest Trades
2024-02-16 | & Johnson Johnson | Disposed 3725 @ 25.81 | View | ||
2024-02-09 | Jennifer L Taubert | Disposed 59397 @ 156.27 | View | ||
2023-12-14 | Jerry Moran | Disposed @ 156.88 | |||
2023-12-05 | Lloyd Doggett | Acquired @ 158.55 | |||
2023-10-24 | Greg Stanton | Disposed @ 151.23 | |||
2023-10-16 | Tommy Tuberville | Disposed @ 157.42 | |||
2023-09-26 | Greg Stanton | Acquired @ 159.02 | |||
2023-09-21 | Pete Ricketts | Disposed @ 161.66 | |||
2023-09-13 | John R. Curtis | Disposed @ 163.99 | |||
2023-09-11 | C. Scott Franklin | Disposed @ 162.66 | |||
2023-09-08 | Lois Frankel | Disposed @ 160.56 | |||
2023-09-07 | Lloyd Doggett | Acquired @ 160.03 | |||
2023-08-24 | Sheldon Whitehouse | Disposed @ 164.89 | |||
2023-08-22 | Dan Sullivan | Disposed @ 166.01 | |||
2023-08-10 | Lois Frankel | Disposed @ 172.18 | |||
2023-08-07 | Michael Guest | Acquired @ 173.1 | |||
2023-07-26 | William Hait | Disposed 14698 @ 172 | View | ||
2023-07-25 | Peter Fasolo | Disposed 20000 @ 170.32 | View |
Monitoring Johnson Johnson's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Johnson Johnson's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Johnson Johnson. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Johnson Johnson's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Johnson |
Johnson Johnson's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Johnson Johnson's future performance. Based on our forecasts, it is anticipated that Johnson will maintain a workforce of nearly 131900 employees by April 2024.Johnson Johnson's latest congressional trading
Congressional trading in companies like Johnson Johnson, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Johnson Johnson by those in governmental positions are based on the same information available to the general public.
2024-01-19 | Representative Blake Moore | Disposed Under $15K | Verify | ||
2023-09-26 | Representative Greg Stanton | Acquired Under $15K | Verify | ||
2023-09-21 | Senator John P Ricketts | Acquired $100K to $250K | Verify | ||
2023-09-11 | Representative C. Scott Franklin | Disposed $15K to $50K | Verify | ||
2023-08-24 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
2023-08-22 | Senator Daniel S Sullivan | Acquired Under $15K | Verify | ||
2022-06-08 | Representative Diana Harshbarger | Acquired Under $15K | Verify | ||
2022-01-18 | Representative Pete Sessions | Disposed $15K to $50K | Verify | ||
2021-09-30 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
2021-05-03 | Representative Richard W. Allen | Acquired $15K to $50K | Verify | ||
2020-10-16 | Representative K. Michael Conaway | Acquired $15K to $50K | Verify | ||
2020-06-12 | Representative David P. Roe | Acquired Under $15K | Verify | ||
2020-04-14 | Senator David A Perdue , Jr | Acquired $50K to $100K | Verify | ||
2020-02-20 | Representative Mikie Sherrill | Disposed Under $15K | Verify | ||
2018-05-25 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
2017-06-15 | Senator Patty Murray | Acquired Under $15K | Verify | ||
2017-06-09 | Senator James M. Inhofe | Acquired $50K to $100K | Verify | ||
2017-01-20 | Senator John Hoeven | Acquired $100K to $250K | Verify | ||
2014-07-23 | Senator Susan M. Collins | Acquired Under $15K | Verify | ||
2014-07-23 | Senator Susan M Collins | Acquired Under $15K | Verify |
Johnson Johnson Management Team Effectiveness
The company has Return on Asset of 0.0833 % which means that on every $100 spent on assets, it made $0.0833 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1831 %, implying that it generated $0.1831 on every 100 dollars invested. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to hike to 0.26 this year. Return On Assets is expected to hike to 0.13 this year. At this time, Johnson Johnson's Total Current Liabilities is relatively stable compared to the past year. Liabilities And Stockholders Equity is expected to hike to about 175.9 B this year, although the value of Change To Liabilities is projected to rise to (962.5 M).The value of Common Stock Shares Outstanding is expected to pull down to about 2.2 B. The value of Net Income Applicable To Common Shares is expected to pull down to about 13 B
Johnson Johnson Workforce Comparison
Johnson Johnson is currently regarded as number one stock in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 152,257. Johnson Johnson totals roughly 131,900 in number of employees claiming about 87% of equities under Health Care industry.
Johnson Johnson Profit Margins
The company has Net Profit Margin of 0.41 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.22 %, which entails that for every 100 dollars of revenue, it generated $0.22 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.77 | 0.686 |
|
| |||||
Net Profit Margin | 0.13 | 0.1664 |
|
| |||||
Operating Profit Margin | 0.18 | 0.2566 |
|
| |||||
Pretax Profit Margin | 0.17 | 0.1769 |
|
| |||||
Return On Assets | 0.13 | 0.0846 |
|
| |||||
Return On Equity | 0.26 | 0.206 |
|
|
Johnson Johnson Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Johnson Johnson insiders, such as employees or executives, is commonly permitted as long as it does not rely on Johnson Johnson's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Johnson Johnson insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.9367 | 74 | 79 | 1,126,871 | 841,041 |
2023-12-01 | 0.5 | 1 | 2 | 227.97 | 12,388 |
2023-09-01 | 0.25 | 2 | 8 | 14,927 | 64,213 |
2023-06-01 | 4.3333 | 13 | 3 | 89,364 | 12,520 |
2023-03-01 | 1.1064 | 52 | 47 | 1,560,338 | 1,435,117 |
2022-12-01 | 0.0563 | 17 | 302 | 424,982 | 808,031 |
2022-06-01 | 0.75 | 6 | 8 | 1,639 | 121,198 |
2022-03-01 | 0.6949 | 82 | 118 | 1,591,197 | 1,210,521 |
2021-12-01 | 1.0 | 4 | 4 | 5,804 | 22,640 |
2021-06-01 | 1.5 | 3 | 2 | 767.89 | 912.00 |
2021-03-01 | 1.3559 | 80 | 59 | 1,535,897 | 616,920 |
2020-12-01 | 1.0 | 4 | 4 | 55,444 | 130,274 |
2020-09-01 | 1.4 | 7 | 5 | 19,996 | 61,230 |
2020-03-01 | 1.0 | 90 | 90 | 2,022,671 | 1,394,742 |
2019-12-01 | 1.0 | 3 | 3 | 7,366 | 4,034 |
2019-09-01 | 1.0 | 1 | 1 | 382.39 | 2,692 |
2019-06-01 | 2.0 | 2 | 1 | 3,350 | 353.00 |
2019-03-01 | 1.0615 | 69 | 65 | 1,211,043 | 1,102,350 |
2018-12-01 | 0.7895 | 15 | 19 | 506,509 | 1,029,964 |
2018-09-01 | 0.2727 | 3 | 11 | 29,684 | 66,041 |
2018-06-01 | 2.0 | 2 | 1 | 757.75 | 385.00 |
2018-03-01 | 1.098 | 56 | 51 | 1,459,455 | 1,396,495 |
2017-12-01 | 1.0 | 4 | 4 | 76,454 | 119,787 |
2017-09-01 | 1.0 | 6 | 6 | 288,991 | 575,950 |
2017-06-01 | 4.0 | 4 | 1 | 1,313 | 409.00 |
2017-03-01 | 1.1077 | 72 | 65 | 2,208,599 | 1,395,624 |
2016-09-01 | 1.5 | 6 | 4 | 45,606 | 88,162 |
2016-06-01 | 0.8571 | 6 | 7 | 8,522 | 23,649 |
2016-03-01 | 1.2292 | 59 | 48 | 1,810,647 | 1,592,510 |
2015-12-01 | 0.8 | 8 | 10 | 72,335 | 128,397 |
2015-06-01 | 1.8 | 9 | 5 | 232,452 | 415,933 |
2015-03-01 | 1.7931 | 52 | 29 | 1,497,466 | 863,712 |
2014-12-01 | 1.625 | 13 | 8 | 124,081 | 80,120 |
2014-09-01 | 3.3333 | 10 | 3 | 31,463 | 60,936 |
2014-06-01 | 1.8571 | 13 | 7 | 26,671 | 50,018 |
2014-03-01 | 2.2273 | 49 | 22 | 1,595,007 | 270,290 |
2013-12-01 | 2.0 | 24 | 12 | 43,879 | 88,621 |
2013-09-01 | 1.5 | 18 | 12 | 151,479 | 218,390 |
2013-06-01 | 4.5 | 9 | 2 | 1,681 | 7,429 |
2013-03-01 | 2.8947 | 55 | 19 | 1,861,702 | 242,918 |
2012-12-01 | 1.3333 | 24 | 18 | 88,061 | 242,611 |
2012-09-01 | 1.3333 | 12 | 9 | 359,037 | 708,892 |
2012-03-01 | 3.8 | 38 | 10 | 2,001,830 | 1,040,386 |
2011-12-01 | 1.4 | 14 | 10 | 355,881 | 705,544 |
2011-06-01 | 2.0 | 8 | 4 | 331,325 | 658,300 |
2011-03-01 | 2.8333 | 34 | 12 | 1,078,290 | 147,164 |
2010-12-01 | 2.4 | 12 | 5 | 23,846 | 41,538 |
2010-09-01 | 1.5 | 12 | 8 | 268,351 | 529,534 |
2010-06-01 | 9.0 | 9 | 1 | 21,323 | 18,000 |
2010-03-01 | 3.3333 | 30 | 9 | 1,019,440 | 123,426 |
2009-12-01 | 1.3846 | 18 | 13 | 114,643 | 230,603 |
2009-09-01 | 2.1429 | 15 | 7 | 188,410 | 411,810 |
2009-06-01 | 2.75 | 11 | 4 | 41,599 | 80,840 |
2009-03-01 | 2.2381 | 47 | 21 | 1,229,737 | 244,806 |
2008-12-01 | 2.8571 | 20 | 7 | 76,055 | 98,292 |
2008-09-01 | 7.0 | 14 | 2 | 5,454 | 6,000 |
2008-06-01 | 0.5714 | 20 | 35 | 138,992 | 270,000 |
2008-03-01 | 4.8889 | 44 | 9 | 1,089,570 | 110,445 |
2007-12-01 | 0.9444 | 17 | 18 | 32,542 | 59,287 |
2007-09-01 | 11.0 | 11 | 1 | 2,422 | 2,640 |
2007-06-01 | 14.0 | 14 | 1 | 4,734 | 1,700 |
2007-03-01 | 4.6667 | 42 | 9 | 1,050,227 | 237,274 |
2006-12-01 | 0.8095 | 17 | 21 | 222,057 | 437,806 |
2006-09-01 | 1.4375 | 23 | 16 | 163,933 | 293,054 |
2006-06-01 | 2.2857 | 16 | 7 | 22,169 | 51,600 |
2006-03-01 | 7.1429 | 50 | 7 | 1,414,193 | 45,960 |
2005-12-01 | 2.0 | 18 | 9 | 72,595 | 95,869 |
2005-09-01 | 2.375 | 19 | 8 | 18,256 | 30,989 |
2005-06-01 | 4.4 | 22 | 5 | 68,622 | 109,600 |
2005-03-01 | 3.9 | 39 | 10 | 1,183,947 | 201,708 |
2004-12-01 | 3.3333 | 20 | 6 | 8,068 | 10,700 |
2004-09-01 | 1.9167 | 23 | 12 | 141,147 | 203,523 |
2004-06-01 | 5.5 | 22 | 4 | 52,068 | 89,200 |
2004-03-01 | 3.4737 | 66 | 19 | 1,467,963 | 540,524 |
2003-12-01 | 1.0 | 34 | 34 | 156,218 | 407,761 |
2003-09-01 | 7.3333 | 22 | 3 | 18,738 | 18,979 |
2003-06-01 | 4.3333 | 13 | 3 | 3,404 | 125,200 |
2003-03-01 | 1.0 | 1 | 1 | 26.00 | 13,800 |
Johnson Johnson Notable Stakeholders
A Johnson Johnson stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Johnson Johnson often face trade-offs trying to please all of them. Johnson Johnson's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Johnson Johnson's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jorge Mesquita | Executive Vice President Worldwide Chairman - Consumer | Profile | |
Jennifer Taubert | Executive Vice President - Worldwide Chairman, Pharmaceuticals | Profile | |
Ashley McEvoy | Executive Vice President - Worldwide Chairman, Medical Devices | Profile | |
Alex Gorsky | Chairman, CEO, Chairman of Executive Committee and Chairman of Fin. Committee | Profile | |
Joaquin Duato | Executive Vice President Worldwide Chairman - Pharmaceuticals | Profile | |
Sandra Peterson | Group Worldwide Chairman and Member of Executive Committee | Profile | |
Thibaut Mongon | Executive Vice President, Worldwide Chairman, Consumer Health | Profile | |
Paulus Stoffels | Worldwide Chairman of Pharmaceuticals, Chief Scientific Officer and Member of Executive Committee | Profile | |
Jasmina Brooks | President Webster | Profile | |
Louise Mehrotra | Vice President Investor Relations | Profile | |
Michael Sneed | Executive Vice President - Global Corporate Affairs and Chief Communication Officer | Profile | |
Kathy Wengel | Executive Vice President Chief Global Supply Chain Officer | Profile | |
Kathryn Wengel | Executive Vice President Chief Global Supply Chain Officer | Profile | |
James Swanson | Executive Vice President, Chief Information Officer | Profile | |
Joseph Wolk | Chief Financial Officer, Executive Vice President | Profile | |
Peter Fasolo | Chief Human Resource Officer, Executive Vice President | Profile | |
Dominic Caruso | CFO, VP of Fin. and Member of Executive Committee | Profile | |
Joseph CPA | Executive CFO | Profile | |
Mary Coleman | Independent Director | Profile | |
Ronald Williams | Independent Director | Profile | |
Anne Mulcahy | Lead Independent Director | Profile | |
Ian Davis | Independent Director | Profile | |
Mark Weinberger | Independent Director | Profile | |
Jennifer Doudna | Independent Director | Profile | |
William Perez | Independent Director | Profile | |
Marillyn Hewson | Independent Director | Profile | |
Mary Beckerle | Independent Director | Profile | |
Darius Adamczyk | Independent Director | Profile | |
Scott Davis | Director | Profile | |
Hubert Joly | Independent Director | Profile | |
Mark McClellan | Independent Director | Profile | |
Charles Prince | Independent Director | Profile | |
Eugene Washington | Independent Director | Profile | |
Susan Lindquist | Independent Director | Profile | |
Michael Ullmann | VP, General Counsel and Member of Executive Committee | Profile | |
Duane Arsdale | Treasurer | Profile | |
Nadja West | Independent Director | Profile | |
Mark Larkins | Worldwide Secretary | Profile | |
Vanessa Broadhurst | Executive Vice President Global Corporate Affairs | Profile | |
Tom Cavanaugh | Company Medicine | Profile | |
D Davis | Independent Director | Profile | |
A Washington | Independent Director | Profile | |
Dirk Brinckman | Chief Officer | Profile | |
Michael Bodner | Global Recovery | Profile | |
Hani Abouhalka | Company Digital | Profile | |
Ahmet Tezel | Group RD | Profile | |
Robert Decker | Controller Officer | Profile | |
Mathai Mammen | Executive Vice President Pharmaceuticals, R&D | Profile | |
Timothy Schmid | Executive MedTech | Profile | |
William Hait | Executive Vice President Chief External Innovation, Medical Safety, Global Public Health Officer | Profile | |
Jessica Moore | Vice Relations | Profile | |
Celine Martin | Group CSS | Profile | |
Elizabeth Forminard | Executive Counsel | Profile | |
Guy MD | Group EMEA | Profile |
About Johnson Johnson Management Performance
The success or failure of an entity such as Johnson Johnson often depends on how effective the management is. Johnson Johnson management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Johnson management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Johnson management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for 2024 | ||
Return On Capital Employed | 0.18 | 0.26 | |
Return On Assets | 0.08 | 0.13 | |
Return On Equity | 0.21 | 0.26 |
The data published in Johnson Johnson's official financial statements usually reflect Johnson Johnson's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Johnson Johnson. For example, before you start analyzing numbers published by Johnson accountants, it's critical to develop an understanding of what Johnson Johnson's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Johnson Johnson's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Johnson Johnson's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Johnson Johnson's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Johnson Johnson. Please utilize our Beneish M Score to check the likelihood of Johnson Johnson's management manipulating its earnings.
Johnson Johnson Workforce Analysis
Traditionally, organizations such as Johnson Johnson use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Johnson Johnson within its industry.Johnson Johnson Manpower Efficiency
Return on Johnson Johnson Manpower
Revenue Per Employee | 645.6K | |
Revenue Per Executive | 1.6B | |
Net Income Per Employee | 101K | |
Net Income Per Executive | 246.8M | |
Working Capital Per Employee | 54.7K | |
Working Capital Per Executive | 133.6M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Johnson Stock analysis
When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
CEOs Directory Screen CEOs from public companies around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Johnson Johnson's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.106 | Dividend Share 4.7 | Earnings Share 5.2 | Revenue Per Share 33.613 | Quarterly Revenue Growth 0.073 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.